ストックスクリーナーアプリを入手
4.46
2.19%
-0.10
アフターアワーズ：
4.12
-0.34
-7.62%
前日終値:
$4.56
開ける：
$4.55
24時間の取引高:
8,009
Relative Volume:
0.05
時価総額：
$6.09M
収益：
-
当期純損益:
$147.90K
株価収益率:
33.71
EPS:
0.1323
ネットキャッシュフロー:
$-199.00K
1週間 パフォーマンス:
+4.21%
1か月 パフォーマンス:
+9.79%
6か月 パフォーマンス:
-50.22%
1年 パフォーマンス:
-94.17%
1日の値動き範囲:
$4.12
$4.55
1週間の範囲:
$3.6659
$4.60
52週間の値動き範囲:
$3.61
$80.00
Advanced Biomed Inc Stock (ADVB) Company Profile
Compare ADVB vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
4.46 | 6.22M | 0 | 147.90K | -199.00K | 0.1323 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Advanced Biomed Inc (ADVB) 最新ニュース
Advanced Biomed Announces Leadership Changes and Board Appointment - tipranks.com
Advanced Biomed (NASDAQ: ADVB) CTO exits as CFO Mingze Yin joins board - Stock Titan
If You Invested $1,000 in Inotiv Inc (NOTV) - Stock Titan
Risks Report: Will Advanced Biomed Inc benefit from seasonality2026 Buyback Activity & Safe Capital Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Stay updated with the stocks that are on the move in today's after-hours session. - chartmill.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com
Gainers Report: Whats Advanced Biomed Incs historical return2026 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
If You Invested $1,000 in Applied Dna Scie (APDN) - Stock Titan
Advanced Biomed to implement 1-for-20 reverse stock split to meet Nasdaq requirement - MSN
Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com
Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Barchart
Glioma Pipeline Expands As 180+ Pharma Companies Advance Several Novel Therapies, Finds Delveinsight Aivita Biomedical, Denovo Biopharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics - Mena FN
These stocks that are showing activity before the opening bell on Tuesday. - chartmill.com
Tech Rally: Should I hold or sell Advanced Biomed Inc nowInflation Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
Advanced Biomed (NASDAQ: ADVB) preserves Nasdaq listing after reverse split restores $1 bid - Stock Titan
Aug Gainers: Whats the fair value of Advanced Biomed Inc stock2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
Market Leaders: Whats the fair value of Advanced Biomed Inc stock2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Catalysts: Is Advanced Biomed Inc currently under institutional pressure2026 PreEarnings & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Dip Buying: What hedge funds are buying ProShares Trust ProShares Ultra FTSE EuropeJuly 2025 PreEarnings & Smart Money Movement Alerts - baoquankhu1.vn
Rally Mode: Should I hold or sell Advanced Biomed Inc nowDividend Hike & Low Risk Entry Point Guides - baoquankhu1.vn
Growth Report: Will JPMPRL benefit from government policyJuly 2025 Macro Moves & AI Enhanced Trading Alerts - baoquankhu1.vn
Aug Summary: Is Advanced Biomed Inc a strong candidate for buy and holdWeekly Profit Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Morning Market Movers: ALTO, GO, TTD, VCIG See Big Swings - RTTNews
Risk On: Should value investors consider ACXPJuly 2025 Short Interest & Long Hold Capital Preservation Plans - baoquankhu1.vn
Surge for ADVB: New Partnerships and Market Strategies Drive Momentum - timothysykes.com
Advanced Biomed Executes Reverse Split to Maintain Nasdaq Listing - TipRanks
Advanced Biomed (NASDAQ: ADVB) completes 1-for-20 reverse stock split - Stock Titan
Volume Report: Is Columbus Acquisition Corp Debt Equity Composite Units stock a good pick for beginnersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Sentiment Review: Does GROY have strong fundamentalsPortfolio Update Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
BioMed Realty and Babraham Research Campus Ltd Complete Lease-Up of Newest Building at Babraham Research Campus, with TRIMTECH Therapeutics and Tagomics - Business Wire
How Advanced Biomed Inc. stock performs during Fed tightening cyclesWeekly Trading Summary & Expert Approved Trade Ideas - mfd.ru
Head-To-Head Contrast: Billiontoone (NASDAQ:BLLN) and Advanced Biomed (NASDAQ:ADVB) - defenseworld.net
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance By Investing.com - Investing.com South Africa
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation - 富途牛牛
Advanced Biomed announces 1-for-20 reverse stock split to regain Nasdaq compliance - Investing.com Canada
Uber to invest over $100 million in autonomous vehicle charging amid robotaxi push - Bitget
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer - Bitget
Advanced Biomed Inc. Announces 1-for-20 Reverse Stock Split Effective February 20, 2026 - Quiver Quantitative
Advanced Biomed Inc. announces 1 for 20 share consolidation - marketscreener.com
Advanced Biomed Inc. Announces 1 For 20 Share Consolidation - TradingView
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Will Advanced Biomed Inc. stock deliver better than expected guidanceJuly 2025 Trade Ideas & Safe Swing Trade Setups - mfd.ru
Advanced Biomed Inc. SEC 10-Q Report - TradingView
Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusCIntegrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - The Manila Times
Nasus Pharma Announces Closing of $15.0 Million Private Placement - Bitget
Advanced Biomed Inc. Announces 120‑Case Feasibility Study - GlobeNewswire
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery - finance.yahoo.com
Advanced Biomed Inc (ADVB) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
大文字化:
|
ボリューム (24 時間):